aid: accrobioscience
name: Accro Bioscience
description: >-
  Accro Bioscience (Suzhou) Limited, trading as Accropeutics, is a clinical-stage biopharmaceutical
  company founded in 2017 with operations in Suzhou, China and New York. It develops small-molecule
  therapeutics against regulated cell death — necroptosis, pyroptosis and ferroptosis — targeting
  the cell-death-to-inflammation loop behind inflammatory, fibrotic, autoimmune and oncology
  disease. Its pipeline is led by AC-101, an oral selective RIPK2 inhibitor in Phase Ib for
  ulcerative colitis with FDA clearance for a Phase II multi-regional IBD study; AC-201, a
  TYK2/JAK1 pseudokinase inhibitor licensed to Fosun Pharma for Greater China as FXS5626; and
  AC-003, a RIPK1 inhibitor in Phase Ib for acute graft-versus-host disease with FDA Orphan Drug
  Designation. It closed a $50M Series C led by OrbiMed in May 2026. Accro Bioscience sells drug
  candidates, not software: it runs no developer program and publishes no API, SDK or
  machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/accrobioscience/refs/heads/main/apis.yml
image: https://www.accropeutics.com/upload/2024-05/171677317462138100.svg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Clinical Trials
- Life Sciences
- Immunology
- Inflammation
- Small Molecule
- Regulated Cell Death
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/accrobioscience-domain-security.yml
- type: Website
  url: https://www.accropeutics.com/
- type: About
  url: https://www.accropeutics.com/about
- type: Newsroom
  url: https://www.accropeutics.com/news
- type: Contact
  url: https://www.accropeutics.com/contact
- type: Partners
  url: https://www.accropeutics.com/partnerships
- type: Careers
  url: https://www.accropeutics.com/join
- type: LinkedIn
  url: https://www.linkedin.com/company/95295041/
- type: SecondaryMarket
  url: https://equityzen.com/company/accrobioscience
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 2
  pass: local-v3
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Accro Bioscience (Suzhou) Limited is a clinical-stage biopharmaceutical company whose product
    is a small-molecule drug pipeline (AC-101, AC-201, AC-003), not software; its entire public
    surface is the accropeutics.com corporate site — about, focus areas, pipeline, partnerships,
    news, join us, contact — with no developer, docs, portal or integration link anywhere in the
    nav or footer, and the site does not even serve a /robots.txt or /sitemap.xml. Every
    REST/GraphQL/agent-card, /llms.txt and /.well-known/ path probed on both www.accropeutics.com
    and accropeutics.com returns an identical 548-byte hard 404, verified against a random control
    path returning the same body and byte count; api., dev., docs., developer., portal., data. and
    mcp..accropeutics.com do not resolve in DNS, and there is no GitHub organization and no npm or
    PyPI package under either the Accro Bioscience or Accropeutics name.
  evidence:
  - url: https://www.accropeutics.com/
    status: 200
  - url: https://www.accropeutics.com/openapi.json
    status: 404
  - url: https://www.accropeutics.com/swagger.json
    status: 404
  - url: https://www.accropeutics.com/api-docs
    status: 404
  - url: https://www.accropeutics.com/graphql
    status: 404
  - url: https://www.accropeutics.com/developers
    status: 404
  - url: https://www.accropeutics.com/llms.txt
    status: 404
  - url: https://www.accropeutics.com/robots.txt
    status: 404
  - url: https://www.accropeutics.com/.well-known/agent-card.json
    status: 404
  - url: https://www.accropeutics.com/.well-known/agent.json
    status: 404
  - url: https://www.accropeutics.com/.well-known/api-catalog
    status: 404
  - url: https://accropeutics.com/.well-known/security.txt
    status: 404
  - url: https://www.accropeutics.com/zz-api-evangelist-control-7c1e
    status: 404
  - url: https://api.github.com/search/users?q=accro+bioscience
    status: 200
  checked: '2026-09-06'